24 May , 15:00–16:15
Business Dialogue
Pavilion G, Conference Hall G22

Russia and Israel share interests and goals when it comes to join tackling of diseases and appreciation for technology and innovation. Can Russian-Israeli cooperation in healthcare secure the new heights for humanity? Can medical innovation become a profitable area at the Russian market? How can government encourage private development of healthcare? What are Russian and Israeli specific areas of expertise when it comes to treating patients? How would Russian healthcare market look like in 5, 10, 15 years?

Igor Vittel, Head, Information and Analytical Centre "Policy and Security" JSC

Eyran Halpern, Executive Director, Rabin Medical Center
Mati Gill, Head of Government Affairs, Corporate Headquarters and Growth Markets, Teva Pharmaceutical Industries Ltd
Kirill Kaem, Senior Vice-President for Innovations, Skolkovo Foundation
Mark Kurtser, Chief Executive Officer, Member of the Board of Directors, MD Medical Group Investments
Siman Tov Moshe Bar, Director General, Ministry of Health of the State of Israel
Jacky Ovadia, Director of International Medicine, Clalit Health Services
Zeev Elkin, Ministry of Environmental Protection of the State of Israel
Tatyana Yakovleva, Deputy Minister of Healthcare of the Russian Federation

Front row participants
German Zakharyaev, President, Regional Public Charitable Foundation of Mountain Jews (STMEGI)
Yury Canner, President, Russian Jewish Congress (RJC)
Gary Koren, Ambassador Extraordinary and Plenipotentiary of the State of Israel to the Russian Federation
Teimuraz Khikhinashvili, Chairman, Israeli–Russian Business Council